Log in

Relevant bibliographies by topics / Exophiala spinifera / Journal articles

To see the other types of publications on this topic, follow the link: Exophiala spinifera.

Journal articles on the topic 'Exophiala spinifera'

Author: Grafiati

Published: 4 June 2021

Last updated: 15 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 34 journal articles for your research on the topic 'Exophiala spinifera.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Tomson, N., A. Abdullah, and M. B. Maheshwari. "Chromomycosis caused by Exophiala spinifera." Clinical and Experimental Dermatology 31, no. 2 (March 2006): 239–41. http://dx.doi.org/10.1111/j.1365-2230.2005.02006.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Fernando Barba-Gómez, J., Jesús Mayorga, Michael R. McGinnis, and Amado González-Mendoza. "Chromoblastomycosis caused by Exophiala spinifera." Journal of the American Academy of Dermatology 26, no. 2 (February 1992): 367–70. http://dx.doi.org/10.1016/0190-9622(92)70058-n.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Oba, Misao, Yoko Suzuki, Masako Kawasaki, and Masahiro Takigawa. "A Case of Cutaneous Exophiala spinifera Infection." Nippon Ishinkin Gakkai Zasshi 41, no. 1 (2000): 17–21. http://dx.doi.org/10.3314/jjmm.41.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Develoux, M., M. T. Dieng, B. Ndiaye, G. Raphenon, and J. P. Lepers. "Chromomycose à Exophiala spinifera en Afrique sahélienne." Annales de Dermatologie et de Vénéréologie 133, no. 1 (January 2006): 68–69. http://dx.doi.org/10.1016/s0151-9638(06)70849-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Daly, Julie-Anne, Vit Hubka, Alena Kubátová, Marina Gimeno, and Vanessa R. Barrs. "Feline disseminated cutaneous phaeohyphomycosis due to Exophiala spinifera." Medical Mycology Case Reports 27 (March 2020): 32–35. http://dx.doi.org/10.1016/j.mmcr.2019.12.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Singal, Archana, Deepika Pandhi, Sambit N. Bhattacharya, Shukla Das, Sarla Aggarwal, and Kiran Mishra. "Pheohyphomycosis caused by Exophiala spinifera: a rare occurrence." International Journal of Dermatology 47, no. 1 (December 17, 2007): 44–47. http://dx.doi.org/10.1111/j.1365-4632.2007.03430.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Radhakrishnan, Deepa, G. Jayalakshmi, A. Madhumathy, SThasneem Banu, S. Geethalakshmi, and G. Sumathi. "Subcutaneous phaeohyphomycosis due to Exophiala spinifera in an immunocompromised host." Indian Journal of Medical Microbiology 28, no. 4 (2010): 396. http://dx.doi.org/10.4103/0255-0857.71838.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Dutriaux, C., I. Saint-Cyr, N. Desbois, D. Calès-Quist, A. Diedhou, and A. M. Boisseau-Garsaud. "Phaéohyphomycose sous-cutanée à Exophiala spinifera chez une malade greffée rénale." Annales de Dermatologie et de Vénéréologie 132, no. 3 (March 2005): 259–62. http://dx.doi.org/10.1016/s0151-9638(05)79258-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Vitale, R. G., and G. S. de Hoog. "Molecular diversity, new species and antifungal susceptibilities in the Exophiala spinifera clade." Medical Mycology 40, no. 6 (December 1, 2002): 545–56. http://dx.doi.org/10.1080/714031149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Liu, Hongfang, Jiao Zhang, Yangxia Chen, Ruzeng Xue, Weiying Zeng, Liyan Xi, and Yongfeng Chen. "Phaeohyphomycosis due to Exophiala spinifera greatly improved by ALA-PDT: A case report." Photodiagnosis and Photodynamic Therapy 28 (December 2019): 297–99. http://dx.doi.org/10.1016/j.pdpdt.2019.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Lee, Weon Ju, Dong Hyuk Eun, Yong Hyun Jang, Seok-Jong Lee, Yong Jun Bang, and Jae Bok Jun. "A Case of Phaeohyphomycosis on the Wrist: Identification of Exophiala spinifera in Korea." Annals of Dermatology 30, no. 2 (2018): 232. http://dx.doi.org/10.5021/ad.2018.30.2.232.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Lin, Y.-P., W. Li, Y.-P. Yang, W.-M. Huang, and Y.-M. Fan. "Cutaneous phaeohyphomycosis caused by Exophiala spinifera in a patient with systemic lupus erythematosus." Lupus 21, no. 5 (November 7, 2011): 548–51. http://dx.doi.org/10.1177/0961203311428460.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Kishi, Fukuko, Kazuko Nishimura, Ayako Sano, Reiko Tanaka, and Makoto Miyaji. "Histopathological Examination of in vitro Bone Degeneration Caused by a Black Yeast, Exophiala spinifera." Nippon Ishinkin Gakkai Zasshi 43, no. 4 (2002): 261–64. http://dx.doi.org/10.3314/jjmm.43.261.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Daboit, Tatiane Caroline, Rodrigo Pereira Duquia, Cibele Massotti Magagnin, Sandra Denise Camargo Mendes, Mauricio Ramírez Castrillón, Raquel Steglich, Inajara Silveira dos Santos, Gerson Vettorato, Patrícia Valente, and Maria Lúcia Scroferneker. "A case of Exophiala spinifera infection in Southern Brazil: Molecular identification and antifungal susceptibility." Medical Mycology Case Reports 1, no. 1 (2012): 72–75. http://dx.doi.org/10.1016/j.mmcr.2012.08.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

de Hoog, G. S., V. Vicente, R. B. Caligiorne, S. Kantarcioglu, K. Tintelnot, A. H. G. Gerrits van den Ende, and G. Haase. "Species Diversity and Polymorphism in the Exophiala spinifera Clade Containing Opportunistic Black Yeast-Like Fungi." Journal of Clinical Microbiology 41, no. 10 (October 1, 2003): 4767–78. http://dx.doi.org/10.1128/jcm.41.10.4767-4778.2003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Vitale, R. G., J. F. G. M. Meis, G. S. Hoog, and P. E. Verweij. "POST ANTIFUNGAL EFFECT OF EXOPHIALA SPINIFERA STRAINS AGAINST AMPHOTERICIN B, ITRACONAZOLE, TERBINAFINE AND 5-FLUOROCYTOSINE." Mycoses 45, S2 (August 2002): 67–68. http://dx.doi.org/10.1111/j.1439-0507.2002.tb04748.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Kaur, J., R. Kaur, R. Datta, S. Kaur, and A. Kaur. "Exploration of insecticidal potential of an alpha glucosidase enzyme inhibitor from an endophytic Exophiala spinifera." Journal of Applied Microbiology 125, no. 5 (September 23, 2018): 1455–65. http://dx.doi.org/10.1111/jam.13947.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Perez, Laura, Fernando Messina, Ricardo Negroni, Alicia Arechavala, Jacinta Bustamante, Matías Oleastro, Mélanie Migaud, Jean-Laurent Casanova, Anne Puel, and Gabriela Santiso. "Inherited CARD9 Deficiency in a Patient with Both Exophiala spinifera and Aspergillus nomius Severe Infections." Journal of Clinical Immunology 40, no. 2 (January 15, 2020): 359–66. http://dx.doi.org/10.1007/s10875-019-00740-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Elmi, Fatemeh, Zahra Etemadifar, and Giti Emtiazi. "Study the effect of environmental factors and different carbon sources on dibenzothiophene desulfurization by Exophiala spinifera." Nova Biologica Reperta 6, no. 1 (May 1, 2019): 79–87. http://dx.doi.org/10.29252/nbr.6.1.79.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Elmi, Fatemeh, Zahra Etemadifar, and Giti Emtiazi. "A novel metabolite (1,3-benzenediol, 5-hexyl) production by Exophiala spinifera strain FM through dibenzothiophene desulfurization." World Journal of Microbiology and Biotechnology 31, no. 5 (March 10, 2015): 813–21. http://dx.doi.org/10.1007/s11274-015-1835-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Srinivas, SahanaM, VykuntarajuK Gowda, S. Mahantesh, Rajeshwari Mannapur, and SanjayK Shivappa. "Chromoblastomycosis associated with bone and central nervous involvement system in an immunocompetent child caused by exophiala spinifera." Indian Journal of Dermatology 61, no. 3 (2016): 324. http://dx.doi.org/10.4103/0019-5154.182425.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Wang, Le, Xiaodong She, Guixia Lv, Yongnian Shen, Qing Cai, Rong Zeng, Caixia Li, et al. "Cutaneous and Mucosal Phaeohyphomycosis Caused by Exophiala spinifera in a Pregnant Patient: Case Report and Literature Review." Mycopathologia 175, no. 3-4 (January 20, 2013): 331–38. http://dx.doi.org/10.1007/s11046-012-9611-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Vitale, R. G. "In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera." Journal of Antimicrobial Chemotherapy 51, no. 5 (April 14, 2003): 1297–300. http://dx.doi.org/10.1093/jac/dkg218.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Singh, Gagandeep, M. R. Shivaprakash, Dipankar De, Prerna Gupta, Sunita Gupta, A. J. Kanwar, and Arunaloke Chakrabarti. "Chronic Disfiguring Facial Lesions in an Immunocompetent Patient Due to Exophiala spinifera: A Case Report and Review of Literature." Mycopathologia 174, no. 4 (June 2, 2012): 293–99. http://dx.doi.org/10.1007/s11046-012-9548-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Li, R. K., and M. G. Rinaldi. "In Vitro Antifungal Activity of Nikkomycin Z in Combination with Fluconazole or Itraconazole." Antimicrobial Agents and Chemotherapy 43, no. 6 (June 1, 1999): 1401–5. http://dx.doi.org/10.1128/aac.43.6.1401.

Full text

Abstract:

ABSTRACT Nikkomycins are nucleoside-peptide antibiotics produced byStreptomyces species with antifungal activities through the inhibition of chitin synthesis. We investigated the antifungal activities of nikkomycin Z alone and in combination with fluconazole and itraconazole. Checkerboard synergy studies were carried out by a macrobroth dilution procedure with RPMI 1640 medium at pH 6.0. At least 10 strains of the following fungi were tested: Candida albicans, other Candida spp., Cryptococcus neoformans, Coccidioides immitis,Aspergillus spp., and dematiacious fungi (includingExophiala jeanselmei, Exophiala spinifera,Bipolaris spicifera, Wangiella dermatitidis,Ochroconis humicola, Phaeoannellomyces werneckii, and Cladophialophora bantiana), and 2 strains each of Fusarium, Scedosporium,Paecilomyces, Penicillium, andTrichoderma spp. A total of 110 isolates were examined. Inocula of fungal elements were standardized by hemacytometer counting or spectrophotometrically. MICs and minimum lethal concentrations (MLCs) were determined visually by comparison of growth in drug-treated tubes with growth in drug-free control tubes. Additive and synergistic interactions between nikkomycin and either fluconazole or itraconazole were observed against C. albicans, Candida parapsilosis, Cryptococcus neoformans, andCoccidioides immitis. Marked synergism was also observed between nikkomycin and itraconazole against Aspergillus fumigatus and Aspergillus flavus. No antagonistic interaction between the drugs was observed with any of the strains tested.

APA, Harvard, Vancouver, ISO, and other styles

26

Vitale, R. G., G. S. De Hoog, and Paul E. Verweij. "In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects." Medical Mycology 41, no. 4 (January 2003): 301–7. http://dx.doi.org/10.1080/13693780310001600822.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Vitale, R. G., J. Afeltra, A. Rijs, J. F. G. M. Meis, G. S. Hoog, and P. E. Verweij. "IN VITRO ACTIVITY OF AMPHOTERICIN B AND ITRACONAZOLE IN COMBINATION WITH 5-FLUOROCYTOSINE, SULFADIAZINE AND QUINOLONES AGAINST EXOPHIALA SPINIFERA STRAINS." Mycoses 45, S2 (August 2002): 67. http://dx.doi.org/10.1111/j.1439-0507.2002.tb04747.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Etemadzadeh, Shekoofeh Sadat, Giti Emtiazi, and Zahra Etemadifar. "Heterotrophic Bioleaching of Sulfur, Iron, and Silicon Impurities from Coal by Fusarium oxysporum FE and Exophiala spinifera FM with Growing and Resting Cells." Current Microbiology 72, no. 6 (February 16, 2016): 707–15. http://dx.doi.org/10.1007/s00284-016-1008-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Hartinger, D., and W. Moll. "Fumonisin elimination and prospects for detoxification by enzymatic transformation." World Mycotoxin Journal 4, no. 3 (August 1, 2011): 271–83. http://dx.doi.org/10.3920/wmj2011.1285.

Full text

Abstract:

A technology to efficiently reduce the concentration of carcinogenic and toxic fumonisins in food and feed would be desirable. This class of mycotoxins is produced by the maize pathogen Fusarium verticillioides and other fungi. Fumonisins are frequently found in maize from the warm growing regions of the world, sometimes in considerable concentrations. Their molecular similarity with sphingolipids enables their binding to mammalian ceramide synthase, and the resulting interference with sphingolipid metabolism. Recently, we reported on a cluster of genes of Sphingopyxis sp. MTA144 which enables this alphaproteobacterium to degrade fumonisins. These and the previously known fumonisin catabolism genes and enzymes from the black yeast Exophiala spinifera and from bacterium ATCC 55552 allow the consideration of prospects for enzymatic detoxification of fumonisins in food and feed. All the known fumonisin catabolism pathways start by hydrolytic release of the two tricarballylic acid side chains, followed by removal of the 2-amino group from the core chain by different enzymatic mechanisms. The potential for application of feed enzymes for fumonisin detoxification in the gastrointestinal tract of animals is discussed, and possible applications in processing of maize for feed or food are also considered. To be able to evaluate the requirement for, and potential of, a new, enzyme-based fumonisin detoxification technology, an overview of the state of the art of fumonisin elimination and the known chemical reactions of fumonisins in processing or decontamination is also given. There is a special focus on the toxicity of hydrolysed fumonisins, because they can be generated from fumonisins both by an established, traditional method of maize processing, nixtamalisation, and by enzymatic biotransformation. As a complement to other approaches, enzymatic degradation of fumonisins to ameliorate the health risk of contaminated maize for animals, and possibly also for humans, seems feasible.

APA, Harvard, Vancouver, ISO, and other styles

30

Sundaramoorthy, Varun, Frederico Duarte, Promila Mohan Raj, Joy S. Michael, and Priscilla Rupali. "Phaeohyphomycosis: A 10-Year Review (2006–2016)." Open Forum Infectious Diseases 4, suppl_1 (2017): S86. http://dx.doi.org/10.1093/ofid/ofx163.038.

Full text

Abstract:

Abstract Background Phaeohyphomycosis is a rare infection caused by dematiaceous (pigmented) fungi, frequently reported in tropical and sub-tropical countries. Data regarding this infection is sparse and comprises mainly of case reports. This study was carried out to review epidemiology, causative spectrum, clinical features, and treatment outcomes in patients with Phaeohyphomycosis. Methods We reviewed 20 cases of culture proven Phaeohyphomycosis over a 10-year period at Christian Medical College, Vellore, South India. Results In our cohort, 16 of the 20 patients were male (80%) with an average age of 42 (range 17–66 years). Most of them (35%) were from Tamil Nadu, India and some from Bhutan and Nepal. Eighty-five percent presented with cutaneous lesions, 5% with involvement of the paranasal sinuses, and 5% each had organ involvement in brain and liver. Possible predisposing factors included type II diabetes mellitus (35%), renal transplantation (30%), long-term use of steroids (15%), and human immunodeficiency virus (5%). For all the patients, the direct microscopy and the culture positivity was 100%. The common species isolated were Cladophialophora bantiana, Cladosporium cladosporoides, Cladosporium sphaerospermum, Phialophora oxyspora, and Exophiala spinifera. Most patients (60%) received monotherapy with itraconazole. Five patients were cured, four had recurrence, one patient died (due to leukemia), and 10 were lost to follow-up. Conclusion Phaeohyphomycosis, though an uncommon infection, causes life-threatening disease in both the immunocompetent and immunocompromised hosts. To our knowledge, this is the largest single-centre retrospective study on Phaeohyphomycosis. Though our follow-up was sub-optimal and possible in only 50%, it was noteworthy that disease recurrence was common. Better understanding of pathogenesis and newer antifungals are needed for optimal cure of this disease. Disclosures All authors: No reported disclosures.

APA, Harvard, Vancouver, ISO, and other styles

31

Harris, John E., Deanna A. Sutton, Adam Rubin, Brian Wickes, G. S. De Hoog, and Carrie Kovarik. "Exophiala spiniferaas a cause of cutaneous phaeohyphomycosis: Case study and review of the literature." Medical Mycology 47, no. 1 (January 2009): 87–93. http://dx.doi.org/10.1080/13693780802412611.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Song, Yinggai, Nickolas Menezes da Silva, Vinicius Almir Weiss, Duong Vu, Leandro F. Moreno, Vania Aparecida Vicente, Ruoyu Li, and G. Sybren de Hoog. "Comparative Genomic Analysis of Capsule-Producing Black Yeasts Exophiala dermatitidis and Exophiala spinifera, Potential Agents of Disseminated Mycoses." Frontiers in Microbiology 11 (April 8, 2020). http://dx.doi.org/10.3389/fmicb.2020.00586.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Singh, Shreya, Shivaprakash M. Rudramurthy, Arvind A. Padhye, Basavaraj M. Hemashetter, Ranganathan Iyer, Vinaykumar Hallur, Anuradha Sharma, et al. "Clinical Spectrum, Molecular Characterization, Antifungal Susceptibility Testing of Exophiala spp. From India and Description of a Novel Exophiala Species, E. arunalokei sp. nov." Frontiers in Cellular and Infection Microbiology 11 (July 2, 2021). http://dx.doi.org/10.3389/fcimb.2021.686120.

Full text

Abstract:

IntroductionExophiala spp. are important opportunist pathogens causing subcutaneous or even fatal disseminated infections in otherwise both immunosuppressed and healthy individuals but there are no systematic studies on the isolates of Exophiala species from India.MethodsTwenty-four isolates of Exophiala species were retrieved from the National Culture Collection of Pathogenic Fungi (NCCPF) and identified phenotypically and by molecular methods (ITS region sequencing) followed by antifungal susceptibility testing (AFST) as per CLSI-M38A3 guidelines. A review of the literature of cases from India was performed up to 1st January 2021 using the Medline and Cochrane database.ResultsE. dermatitidis (n = 8), E. jeanselmei (n = 6), E. spinifera (n = 6), E. mesophila (n = 1), E. oligosperma (n = 1), E. xenobiotica (n = 1) were identified and the sequencing of ITS, β-tubulin and β-actin revealed a novel species, E. arunalokei sp. nov. (n = 1). The ITS sequence phylogram of E. jeanselmei revealed that the majority (83%) formed a separate cluster close to type A while majority (75%) of E. dermatitidis were type B. The MIC50 (mg/L) of amphotericin, itraconazole, voriconazole, micafungin, caspofungin, anidulafungin, and posaconazole, was 1, 0.25, 0.125, 0.12, 0.125, 0.062, and 0.062, respectively. Sixteen more cases were identified on the literature review and a significant association of E. dermatitidis with history of surgical procedures (p = 0.013), invasive disease (p = 0.032) and of E. mesophila with tuberculosis (p = 0.026) was seen.ConclusionThis, to the best of our knowledge is the first study from India elucidating the molecular and clinical characteristics of Exophiala species and the first Indian report of human infection due to E. xenobiotica and E. arunalokei.

APA, Harvard, Vancouver, ISO, and other styles

34

Song, Yinggai, Minghao Du, Nickolas Menezes da Silva, Ence Yang, Vania A. Vicente, G. Sybren de Hoog, and Ruoyu Li. "Comparative Analysis of Clinical and Environmental Strains of Exophiala spinifera by Long-Reads Sequencing and RNAseq Reveal Adaptive Strategies." Frontiers in Microbiology 11 (July 31, 2020). http://dx.doi.org/10.3389/fmicb.2020.01880.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!